CN Patent

CN105906616A — Lde225单磷酸盐的晶型及其制备方法

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-08-31 · 10y expired

What this patent protects

本发明涉及LDE225单磷酸盐的晶型及其制备方法。本发明的式(Ⅰ)化合物(LDE225)的单磷酸盐的晶型引湿性低，方便保存且稳定性比现有技术中的二磷酸盐更好，能避免药物开发和生产过程中发生转晶的风险。其制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

USPTO Abstract

本发明涉及LDE225单磷酸盐的晶型及其制备方法。本发明的式(Ⅰ)化合物(LDE225)的单磷酸盐的晶型引湿性低，方便保存且稳定性比现有技术中的二磷酸盐更好，能避免药物开发和生产过程中发生转晶的风险。其制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN105906616A
Jurisdiction
CN
Classification
—
Expires
2016-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.